Testing effectiveness (Phase 2)Study completedNCT06274489What this trial is testingEvaluate Setanaxib in Patients With Alport SyndromeWho this might be right forAlport Syndrome Calliditas Therapeutics AB 20
Not applicableStudy completedNCT01465126What this trial is testingEnalapril in Collagen Type 4 NephropathyWho this might be right forCollagen Type-4 Nephropathies University of Sao Paulo 19
Not applicableEnrolling By InvitationNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375
Testing effectiveness (Phase 2)UnknownNCT05448755What this trial is testingELX-02 in Patients With Alport SyndromeWho this might be right forAlport Syndrome Eloxx Pharmaceuticals, Inc. 8
Not applicableStudy completedNCT02136862What this trial is testingATHENA: Natural History of Disease Study in Alport Syndrome PatientsWho this might be right forAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 Genzyme, a Sanofi Company 165
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731192What this trial is testingHuman Umbilical Cord Mesenchymal Stem Cells for Alport SyndromeWho this might be right forAlport Syndrome Guangzhou Women and Children's Medical Center 40
Not applicableStudy completedNCT01696253What this trial is testingMulti-center Controlled Clinical Trials in Alport Syndrome-A Feasibility StudyWho this might be right forAlport Syndrome University of Minnesota 360
Testing effectiveness (Phase 2)Looking for participantsNCT05003986What this trial is testingStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more Travere Therapeutics, Inc. 67
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920What this trial is testingAtrasentan in Patients With Proteinuric Glomerular DiseasesWho this might be right forIgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more Novartis Pharmaceuticals 103
Not applicableNot Yet RecruitingNCT05133050What this trial is testingSafety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 VariantsWho this might be right forAlport Syndrome Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07211685What this trial is testingBAY3401016; Biomarker Study AlportWho this might be right forAlport Syndrome Bayer 60
Large-scale testing (Phase 3)Study completedNCT01485978What this trial is testingEfficacy and Safety Study to Delay Renal Failure in Children With Alport SyndromeWho this might be right forRenal Insufficiency, Chronic Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 66
Not applicableEnded earlyNCT02718027What this trial is testingBiomarker for Alport Syndrome (BioAlport)Who this might be right forNephritis, HereditaryHematuria-Nephropathy-Deafness Syndrome CENTOGENE GmbH Rostock 12
Not applicableLooking for participantsNCT05927467What this trial is testingEurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)Who this might be right forAlport Syndrome Institut National de la Santé Et de la Recherche Médicale, France 700
Not applicableStudy completedNCT03074357What this trial is testingUrine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.Who this might be right forAlport Nephropathy Novartis Pharmaceuticals 68
Not applicableStudy completedNCT01705132What this trial is testingUrinary Biomarkers of the Progression of Alport Kidney DiseaseWho this might be right forAlport Syndrome University of Minnesota 80
Large-scale testing (Phase 3)Looking for participantsNCT05944016What this trial is testingPhase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult PatientsWho this might be right forChronic Kidney Failure in Children and Young Adults University Hospital Goettingen 102
Not applicableLooking for participantsNCT02378805What this trial is testingAlport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport SyndromeWho this might be right forAlport SyndromeHereditary Kidney DiseasePediatric Kidney Disease+2 more University Hospital Goettingen 800